INS and type 2 diabetes mellitus: Only those with more severe beta cell decompensation require exogenous insulin to manage their diabetes, and so insulin treatment becomes a de facto marker for endogenous insulin deficiency in the face of the insulin resistance in type 2 diabetes (36).